Protocol | Criteria | Infusion of Vamin-18 (before June 1st 2016) | Infusion of arginine/lysine mixture (after June 1st 2016) |
---|---|---|---|
Aa | Pre-therapeutical standard GFR ≥ 50 ml/min/1.73m2 | 1 l solution over 4 h starting ½ hour pre-treatment | 1 l solution and 1 l saline over 4 h starting ½ hour pre-treatment |
B | Pre-therapeutical standard GFR of 40–49 ml/min/1.73m2, previous PRRT or multiple risk factors (e.g. nephrotoxic chemotherapy, longstanding diabetes or hypertension) | 3 l solution over 12 h starting ½ hour pre-treatment | 2 l solution and 1 l saline infused over 12 h starting 1 h pre-treatment. Additionally ½ l solution infused over 2 h starting 24 h post-treatment |
C | Pre-therapeutical standard GFR of 30–39 ml/min/1.73m2 | 4 l solution over about 24 h starting ½ hour pre-treatment (150–170 ml/h) | 3 l solution and 1–2 l saline infused over 24–36 h starting 1 h pre-treatment. Additionally ½ l solution infused over 2 h starting 48 h post-treatment |